Longitudinal Dermoscopic and LC-OCT Monitoring of Facial Vitiligo Treated With Topical Ruxolitinib: A Pilot Prospective Study

Luca Ambrosio; Arlind Kalaja; Mauro Picardo; Qinyi Chen; Claudio Conforti; Giovanni Pellacani; Ignazio Stanganelli; Claudio Feliciani; Alessia Paganelli

doi:10.1111/ijd.70474

Longitudinal Dermoscopic and LC-OCT Monitoring of Facial Vitiligo Treated With Topical Ruxolitinib: A Pilot Prospective Study

Int J Dermatol. 2026 May 14. doi: 10.1111/ijd.70474. Online ahead of print.

Authors

Luca Ambrosio^{1

2}, Arlind Kalaja³, Mauro Picardo¹, Qinyi Chen¹, Claudio Conforti^{1

4}, Giovanni Pellacani², Ignazio Stanganelli^{3

5}, Claudio Feliciani³, Alessia Paganelli^{1

4}

Affiliations

¹ IDI-IRCCS Dermatological Research Hospital, Rome, Italy.
² Dermatology Unit, Department of Medical and Cardiovascular Sciences, "Sapienza" University of Rome, Rome, Italy.
³ Dermatology Resident Training Program, Department of Medicine and Surgery, University of Parma, Parma, Italy.
⁴ Department of Life Science, Health, and Health Professions, Link Campus University of Rome, Rome, Italy.
⁵ Skin Cancer Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori "Dino Amadori"-IRST Meldola, Meldola, Italy.

PMID: 42132903
DOI: 10.1111/ijd.70474

No abstract available

Keywords: JAK inhibitors; LC‐OCT; Ruxolitinib; dermoscopy; facial vitiligo; line‐field confocal optical coherence tomography; skin microstructure; treatment monitoring; vitiligo.